Christi J. Steendam
Eindhoven, NB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
AI-HOPE lung cancer: a multicenter real-world registry integrating artificial intelligence for metastatic non-small-cell lung cancer.
Journal: ESMO real world data and digital oncology
Published: August 14, 2026
Clinical risk factors for developing brain metastases during first-line (chemo-)immunotherapy in patients with non-small cell lung cancer without known baseline brain metastases.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 28, 2025
Prospective clinical evaluation of cell-free DNA next generation sequencing in patients with suspected metastatic lung cancer.
Journal: Scientific reports
Published: April 30, 2025
Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment.
Journal: Clinical pharmacology and therapeutics
Published: February 03, 2025
Connecting the dots: (RANKL+) extracellular vesicle count in blood plasma in relation to bone metastases, skeletal related events and osimertinib treatment in patients with EGFR mutated non-small cell lung cancer.
Journal: Translational lung cancer research
Published: October 25, 2024
Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC.
Journal: JTO clinical and research reports
Published: September 01, 2023
Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinib.
Journal: CPT: pharmacometrics & systems pharmacology
Published: May 10, 2023
Chemotherapy for patients with EGFR-mutated NSCLC after progression on EGFR-TKI's: Exploration of efficacy of unselected treatment in a multicenter cohort study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 15, 2023
Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer.
Journal: EClinicalMedicine
Published: February 11, 2023
Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer.
Journal: International journal of cancer
Published: December 29, 2022
Incidence of Bone Metastases and Skeletal-Related Events in Patients With EGFR-Mutated NSCLC Treated With Osimertinib.
Journal: JTO clinical and research reports
Published: September 22, 2022
Improving the tolerability of osimertinib by identifying its toxic limit.
Journal: Therapeutic advances in medical oncology
Published: February 07, 2022
Last Updated: 09/26/2026